EKTAF
Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity, a MR-Linac technology; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for advanced image-guided radiation therapy; treatment management solutions; automated and integrated quality assurance solutions; and hardware and software motion management technology. It also provides MOSAIQ Plaza for multidisciplinary cancer care; Elekta Axis Cloud, a managed hosting service; Elekta Studio, an image-guided brachytherapy solution; ImagingRing, a mobile CT scanner; Oncentra Brachy, a smart tool that facilitate repetitive tasks; Venezia applicator that enables the radiation oncologist to treat locally advanced cervical cancer; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; and Geneva, an applicator for cervical cancer treatment. In addition, the company offers Leksell Gamma Knife Icon for personalized radiation treatment; Leksell Gamma Knife Perfexion, a tool for neurosurgeons; Leksell Gamma Knife Lightning for accelerated radiosurgery. Further, it provides neurosurgery products comprising Leksell Vantage Stereotactic System for intracranial neurosurgery; and Leksell Stereotactic System or minimally invasive stereotactic neurosurgery. The company was incorporated in 1972 and is headquartered in Stockholm, Sweden.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q4 | -2.21 | $4.7B | $1.3B |
| 2026 Q3 | 0.03 | $4.2B | $498M |
| 2025 Q2 | 0.60 | $4.1B | $65M |
| 2025 Q1 | 0.28 | $3.6B | -$361M |
| 2025 Q4 | -1.01 | $5.2B | $1.2B |
| 2025 Q3 | 0.89 | $4.7B | $729M |
| 2024 Q2 | 0.55 | $4.3B | -$32M |
| 2024 Q1 | 0.18 | $3.8B |
| -$890M |